All treatments
Treatment
Entresto 24 mg/26 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Sacubitril-Valsartan in Heart Failure with Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation (PRAISE-MR)
This study looks at how a medicine called Entresto might help people with a common type of heart failure and a leaky heart valve. Researchers want to see if Entresto improves heart function and symptoms over 6 months.
For: Heart failure with preserved ejection fraction Secundary mitral valve regurgitationBelgium - Ongoing, recruitingTherapeutic use (Phase IV)
Pulmonary REsistance modification under treatment with Sacubitil/valsartaN in paTients with HeartFailure with reduced ejection fraction
This study looks at how a drug called Entresto affects blood pressure in the lungs and how easily blood flows through them, in people with a type of heart failure where the heart struggles to pump blood.
For: Heart Failure with reduced ejection fraction.Poland